Inhaled dual M3 antagonist/PDE4 inhibitor

intratracheal efficacy in model, not developed

from linking M3 antag. + PDE inh. and opt.

Journal of Medicinal Chemistry

Chiesi Farmaceutici S.p.A., Parma, IT

CHF-6001

10. The Chiesi M3 antagonist/PDE4 inhibitor dual pharmacology molecule, compound 92a, is an inhaled compound intended for pulmonary diseases. Both M3 and PDE4 are clinically validated targets for COPD…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: